Early diagnosis of cryptococcal meningitis among people living with HIV (PLHIV) is crucial for its therapeutic success. The objective of this study was to diagnose cryptococcal meningitis in PLHIV cases using the available laboratory techniques for its confirmation in resource limited setting. This cross-sectional prospective study was conducted among 72 PLHIV with clinical suspicion of meningitis. Each cerebrospinal fluid (CSF) sample received at the National Public Health Laboratory, Kathmandu was processed for India ink staining, cryptococcal antigen lateral flow assay, and fungal culture following standard protocols. The laboratory-confirmed cryptococcal meningitis cases were between 24 and 69 years of age (median age 39 years) with 87.5% (12/14) of cases being male. Cryptococcus was detected in 22.22% (16/72) by any of the three tests, 19.44% (14/72) by cryptococcal antigen lateral flow assay, 16.66% (12/72) by India ink staining, and 8.33% (6/72) by culture. High percentage of cryptococcal meningitis among PLHIV warrants early microbiological diagnosis for better case management. Cryptococcal antigen detection immunoassay should be the priority test for laboratory diagnosis of cryptococcal meningitis in PLHIV. Alternatively, very simple and economic India ink staining of CSF specimens could be used in resource limited settings.

CONFLICT OF INTEREST

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Open Research

DATA AVAILABILITY STATEMENT

The data generated or analyzed during this study are included in this published article.

REFERENCES

1Spec A, Powderly WG. Cryptococcal meningitis in AIDS. Handb Clin Neurol. 2018; 152: 139-150. doi:10.1016/B978-0-444-63849-6.00011-6
10.1016/B978-0-444-63849-6.00011-6
PubMed Google Scholar
2 WHO. Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children- Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing Hiv Infection. World Health Organization; 2018.
Google Scholar
3Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4): 525-530.
10.1097/QAD.0b013e328322ffac
PubMed Web of Science® Google Scholar
4Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis. 2021; 72(Suppl 2): S121-S127. doi:10.1093/cid/ciaa1751
10.1093/cid/ciaa1751
PubMed Web of Science® Google Scholar
5Jha A, Adhikari S, Sigdel KR, et al. Case report: cryptococcal meningitis in an apparently immunocompetent patient in Nepal–challenges in diagnosis and treatment. Wellcome Open Res. 2019; 4: 55.
10.12688/wellcomeopenres.15187.2
PubMed Google Scholar
6Khanal B, Sharma SK, Deb M. Cryptococcal meningitis in a non-aids patient. J Nepal Med Association. 2002; 41: 323-325.
10.31729/jnma.759
Google Scholar
7 NCASC. National HIV Testing and Treatment Guidelines. NCASC; 2020.
Google Scholar
8 WHO. Laboratory Manual for Diagnosis of Fungal Opportunistic Infections in HIV/AIDS Patient. WHO; 2009.
Google Scholar
9 G William, RJH Merz, eds. Topley and Wilson's Microbiology and Microbial Infections: Medical Mycology. Tenth ed., Wiley; 2007.
Google Scholar
10 http://www.immy.com/products/lateral-flow-assays/crag-lfa/#1473450453921-a2843b7f-7b86
Google Scholar
11Kwizera R, Akampurira A, Williams D, Boulware DR, Meya DB. Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients. PLoS One. 2017; 12(7):e0182108.
10.1371/journal.pone.0182108
PubMed Web of Science® Google Scholar
12Corp IBM. IBM SPSS Statistics for Windows, Version 21.0. IBM Corp; 2012.
Google Scholar
13Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017; 17(8): 873-881.
10.1016/S1473-3099(17)30243-8
PubMed Web of Science® Google Scholar
14Nyazika TK, Tatuene JK, Kenfak-Foguena A, et al. Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950–2017: protocol for a systematic review. BMJ Open. 2018; 8(7):e020654.
10.1136/bmjopen-2017-020654
PubMed Web of Science® Google Scholar
15Oladele RO, Bongomin F, Gago S, Denning DW. HIV-associated cryptococcal disease in resource-limited settings: a case for "prevention is better than cure"? J Fungi (Basel). 2017; 3(4): 67.
10.3390/jof3040067
PubMed Google Scholar
16Kharel G, Karn R, Rajbhandari R, Ojha R, Agrawal J. Spectrum of cryptococcal meningoencephalitis in tertiary hospital in Nepal. J Inst Med. 2018; 40(2): 27-32.
Google Scholar
17Khanal VK, Jha N, Karki P, Paudel IS. Opportunistic infections and clinical profile of HIV/AIDS patients: a study from eastern region of Nepal. Nepal Med Coll J. 2014; 16(2–4): 194-197.
CAS PubMed Google Scholar
18Dhungel BA, Dhungel KU, Easow JM, Singh YI. Opportunistic infection among HIV seropositive cases in Manipal teaching hospital, Pokhara, Nepal. Kathmandu Univ Med J (KUMJ). 2008; 6(23): 335-339.
CAS PubMed Google Scholar
19Sall O, Thulin Hedberg S, Neander M, et al. Etiology of central nervous system infections in a rural area of Nepal using molecular approaches. Am J Trop Med Hyg. 2019; 101(1): 253-259.
10.4269/ajtmh.18-0434
PubMed Web of Science® Google Scholar
20Radheshyam KC, Karkey A, Prajapati KG, Baker S, Basnyat B. Fatal cryptococcal meningitis in a HIV-seronegative patient with liver cirrhosis. JMM Case Rep. 2014; 1(3):e001982.
10.1099/jmmcr.0.001982
Google Scholar
21Pandey P, Jha B, Shrestha A. Etiology of meningitis from patients suspected of meningitis attending Tribhuvan university teaching hospital, Kathmandu, Nepal. Current Res Microbiol. 2015; 6(2): 21-30.
10.3844/ajmsp.2015.21.30
Google Scholar
22Kra O, Aba YT, Yao KH, et al. Clinical, biological, therapeutic and evolving profile of patients with HIV infection hospitalized at infectious and tropical diseases unit in Abidjan (Ivory Coast). Bull Soc Pathol Exot. 2013; 106(1): 37-42.
10.1007/s13149-012-0246-9
CAS PubMed Google Scholar
23Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One. 2013; 8(4):e62390.
10.1371/journal.pone.0062390
CAS PubMed Web of Science® Google Scholar
24 CDC. Cryptococcal Screening Program: Training Modules for Laboratory Workers. CDC; 2013.
Google Scholar
25Bahr NC, Boulware DR. Methods of rapid diagnosis for the etiology of meningitis in adults. Biomark Med. 2014; 8(9): 1085-1103.
10.2217/bmm.14.67
CAS PubMed Web of Science® Google Scholar
26Barenfanger J, Lawhorn J, Drake C. Nonvalue of culturing cerebrospinal fluid for fungi. J Clin Microbiol. 2004; 42(1): 236-238.
10.1128/JCM.42.1.236-238.2004
PubMed Web of Science® Google Scholar
27Skipper C, Tadeo K, Martyn E, et al. Evaluation of serum cryptococcal antigen testing using two novel Semiquantitative lateral flow assays in persons with cryptococcal Antigenemia. J Clin Microbiol. 2020; 58(4): e02046-e02019. doi:10.1128/JCM.02046-19
10.1128/JCM.02046-19
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume66, Issue1

January 2023

Pages 47-51

Cryptococcal meningitis in people living with human immunodeficiency virus in Nepal: Perspectives from resource limited setting

Abstract

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Cryptococcal meningitis in people living with human immunodeficiency virus in Nepal: Perspectives from resource limited setting

Abstract

CONFLICT OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

Citing Literature

References

Related

Information